Back to homepage

Tag "Bharat Biotech"

Bharat Biotech seeks nod for Covaxin booster trials for 2-18 age group

Bharat Biotech seeks nod for Covaxin booster trials for 2-18 age group

🕔06:30, 5.May 2022

Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population. New Delhi, May 5 (IANS) Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of

Read Full Article
Ocugen to commercialise Covaxin in Mexico

Ocugen to commercialise Covaxin in Mexico

🕔06:46, 19.Apr 2022

Ocugen, a biotechnology company focused on discovering, developing, and commercialising novel gene therapies, biologicals and vaccines, and Bharat Biotech, announced that they have entered into an amendment to their agreement to expand Ocugen’s exclusive territory to include commercialisation of Covaxin

Read Full Article
Bharat Biotech upgrading facilities as WHO suspends Covaxin supplies

Bharat Biotech upgrading facilities as WHO suspends Covaxin supplies

🕔07:31, 4.Apr 2022

After the World Health Organisation (WHO) suspended the supply of Bharat Biotech’s Covaxin vaccine under the United Nations (UN) procurement after an inspection last month, the company has said it is working on upgrades to ensure that the production of

Read Full Article
Covishield, Covaxin cleared for regular market approval

Covishield, Covaxin cleared for regular market approval

🕔07:07, 20.Jan 2022

New Delhi, Jan 20 (IANS) India’s two main vaccines — Bharat Biotechs Covaxin and Serum Institute of India’s Covishield — on Wednesday got the nod for regular market authorisation. An expert panel of Central Drugs Standard Control Organisation (CDSCO) — India’s

Read Full Article
Ensure only Covaxin is given to 15-18 group: Bharat Biotech

Ensure only Covaxin is given to 15-18 group: Bharat Biotech

🕔07:12, 19.Jan 2022

Hyderabad, Jan 19 (IANS) Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group. The Hyderabad-based vaccine maker on Tuesday said that it “received several additional reports of individuals in

Read Full Article
Bharat Biotech targets one billion doses of intranasal vaccine annually

Bharat Biotech targets one billion doses of intranasal vaccine annually

🕔18:54, 28.Dec 2021

Hyderabad, Dec 28 (IANS) Bharat Biotech is targeting to make one billion doses of its Covid-19 intranasal vaccine annually while it is on track to achieve one billion doses of Covaxin, India’s first indigenous Covid vaccine. The Hyderabad-based vaccine maker has

Read Full Article
Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine

Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine

🕔07:09, 21.Dec 2021

Hyderabad, Dec 21 (IANS) Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine, sources said on Monday. The Hyderabad-based vaccine maker has submitted the application and

Read Full Article
Opened Covaxin vial can be stored for 28 days, says Bharat Biotech

Opened Covaxin vial can be stored for 28 days, says Bharat Biotech

🕔21:23, 20.Dec 2021

Hyderabad, Dec 20 (IANS) An opened vial of Covid-19 vaccine Covaxin can be stored at 2 to 8 degrees Celsius for up to 28 days and is not required to be discarded immediately in a day or at the end of

Read Full Article
Vietnam India to host Business Forum 2021

Vietnam India to host Business Forum 2021

🕔11:46, 17.Dec 2021

New Delhi, Dec 17 On the occasion of the official visit to the Republic of India from December 15 to 19, 2021 of Vuong Dinh Hue, President of the National Assembly at the invitation of H.E. Mr. Venkaiah Naidu, Chairman

Read Full Article
Bharat Biotech’s US partner Ocugen seeks Covaxin approval for kids

Bharat Biotech’s US partner Ocugen seeks Covaxin approval for kids

🕔12:44, 6.Nov 2021

New Delhi, Nov 6 (IANS) Hyderabad-based pharma major Bharat Biotech’s US partner Ocugen has sought the Emergency Use Authorisation (EUA) from the US FDA for Covaxin to be administered in children aged two to 18 years. Ocugen said that it has

Read Full Article
India’s indigenous Covaxin gets WHO nod

India’s indigenous Covaxin gets WHO nod

🕔22:05, 3.Nov 2021

Hyderabad, Nov 3 (IANS) The Hyderabad-based Bharat Biotech announced on Wednesday that the World Health Organisation (WHO) has franted Emergency Use Listing to India’s first indigenous Covid-19 vaccine Covaxin. Developed by Bharat Biotech in partnership with the Indian Council of Medical

Read Full Article
After Australia, 5 more countries recognise India’s Covaxin

After Australia, 5 more countries recognise India’s Covaxin

🕔07:48, 2.Nov 2021

New Delhi, Nov 2 (IANS) After Australia recognised Bharat Biotech’s Covaxin for allowing entry of travellers who had received the vaccine, five more countries on Monday recognised India’s vaccine certificate. These five countries recognised both Covaxin and Covishield. The Ministry of

Read Full Article
Proud to contribute to 1 bn vaccinations: Bharat Biotech

Proud to contribute to 1 bn vaccinations: Bharat Biotech

🕔16:37, 21.Oct 2021

Hyderabad, Oct 21 (IANS) Covid-19 vaccine Covaxin maker Bharat Biotech on Thursday said it was proud to contribute to India reaching the one billion-mark of Covid vaccinations. The Hyderabad-based vaccine maker said that reaching the one billion-mark in just nine-months is

Read Full Article
No compromise on Covaxin quality, says Bharat Biotech

No compromise on Covaxin quality, says Bharat Biotech

🕔06:57, 6.Aug 2021

Hyderabad, Aug 6  Amid concerns in some quarters about the safety of Covaxin, Bharat Biotech has clarified that its Covid-19 vaccine is totally safe and that it is following uncompromising policy on safety and quality. The Hyderabad-based company’s clarification came

Read Full Article
Bharat Biotech’s Rotavac 5D receives WHO prequalification

Bharat Biotech’s Rotavac 5D receives WHO prequalification

🕔19:57, 2.Aug 2021

Hyderabad, Aug 2  Bharat Biotech on Monday announced that the World Health Organisation (WHO) has awarded prequalification to its rotavirus vaccine, Rotavac 5D. The new variant of Rotavac is a unique rotavirus vaccine formulation that can be administered without a

Read Full Article
Review process begins for WHO listing of Covaxin: Bharat Biotech

Review process begins for WHO listing of Covaxin: Bharat Biotech

🕔07:12, 13.Jul 2021

Hyderabad, July 13  Bharat Biotech on Monday said that it has submitted all documents to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its Covid-19 vaccine Covaxin and the review process has commenced. Bharat Biotech Chairman and

Read Full Article
‘Mann Ki Baat’: PM urges people to overcome vaccine hesitancy

‘Mann Ki Baat’: PM urges people to overcome vaccine hesitancy

🕔12:45, 27.Jun 2021

New Delhi, June 27 (IANS) In his 78th edition of the monthly ‘Mann Ki Baat’ radio programme, Prime Minister Narendra Modi on Sunday appealed to people to shun Covid-19 vaccine hesitancy and ensure jabs to them and their family members to

Read Full Article
Bharat Biotech supplies Covaxin to 16 states

Bharat Biotech supplies Covaxin to 16 states

🕔14:55, 16.Jun 2021

Hyderabad, June 16  Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments. Company’s co-founder and joint managing director Suchitra Ella on Wednesday tweeted that Andhra

Read Full Article
Bharat Biotech expects WHO approval for Covaxin by July-Sep

Bharat Biotech expects WHO approval for Covaxin by July-Sep

🕔07:44, 26.May 2021

Hyderabad, May 26  Bharat Biotech has said on Tuesday that it is expecting regulatory approvals from the World Health Organisation (WHO) for its Covid-19 vaccine Covaxin by July-September 2021. The Hyderabad-based company stated that application for Emergency Use Listing (EUL)

Read Full Article
Covaxin supplied to 30 cities in 30 days

Covaxin supplied to 30 cities in 30 days

🕔19:26, 25.May 2021

Hyderabad, May 25  Bharat Biotech has supplied its Covid-19 vaccine Covaxin to 30 cities in India within 30 days, a top company official said on Tuesday. “Covaxin reaches 30 cities within 30 days,” tweeted Suchitra Ella, Co-founder and Joint Managing

Read Full Article